The Impact of Ketoanalogues on Nephropathy Progression in Advanced Chronic Kidney Disease Older Patients
| datacite.rights | http://purl.org/coar/access_right/c_abf2 | spa |
| dc.contributor.author | Aroca-Martinez, Gustavo | |
| dc.contributor.author | Sierra, Angélica | |
| dc.contributor.author | Barros-Camargo, Luis | |
| dc.contributor.author | Pertuz-Pinzon, Adolfo | |
| dc.contributor.author | Dianda, Daniela | |
| dc.contributor.author | Cadena-Bonfanti, Andrés | |
| dc.contributor.author | Musso, Carlos G. | |
| dc.date.accessioned | 2022-12-06T19:54:42Z | |
| dc.date.available | 2022-12-06T19:54:42Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Advanced chronic kidney disease (CKD) can be treated with conservative care or renal replacement therapies. CKD is associated with an increased risk of nephropathy progression, and death. Therefore, slow down CKD progression is crucial, and there is consensus regarding protein intake regulation benefit in delaying this progression. Ketoanalogues are nitrogen-free analogs of essential amino acids which supplements low protein diets. Thus, it was decided to evaluate if keto diet had benefit in reducing CKD progression | eng |
| dc.format.mimetype | spa | |
| dc.identifier.doi | DOI: 10.31080/ASNH.2022.06.1156 | spa |
| dc.identifier.issn | 25821423 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/11632 | |
| dc.identifier.url | https://www.actascientific.com/ASNH/pdf/ASNH-06-1156.pdf | eng |
| dc.language.iso | eng | eng |
| dc.publisher | Acta Scientific Publications | eng |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.source | Acta Scientific Nutritional Health | eng |
| dc.source | Act. Sci. Nutr. Health | eng |
| dc.source | Vol. 6 No. 12 (2022) | eng |
| dc.subject | Chronic Kidney Disease | eng |
| dc.subject | Ketoanalogues | eng |
| dc.subject | Progression | eng |
| dc.title | The Impact of Ketoanalogues on Nephropathy Progression in Advanced Chronic Kidney Disease Older Patients | spa |
| dc.type.driver | info:eu-repo/semantics/article | spa |
| dc.type.spa | Artículo científico | spa |
| dcterms.references | Scalone L., et al. “Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients”. Nephrology Dialysis Transplantation 25 (2010): 907-913 | eng |
| dcterms.references | Perez-Gomez MV., et al. “Clarifying the concept of chronic kidney disease for non-nephrologists”. Clinical Kidney Journal 12.2 (2019): 258-261 | eng |
| dcterms.references | Musso CG and Jauregui JR. “How to differentiate renal senescence from chronic kidney disease in clinical practice”. Postgraduate Medicine 128.7 (2016): 716-721. | eng |
| dcterms.references | Chen TK., et al. “Chronic kidney disease diagnosis and management. A Review”. JAMA 322.13 (2019): 1294-1304. | eng |
| dcterms.references | Brunori G. “Treatment of chronic kidney disease in the elderly: diet or conservative management”. Journal of Nephrology 25.19 (2012): S28-S31. | eng |
| dcterms.references | Musso CG., et al. “Therapeutic alternatives and palliative care for advanced renal disease in the very elderly: a review of the literature”. International Urology and Nephrology 47.4 (2015): 647-654. | eng |
| dcterms.references | Bellizzi V., et al. “A Delphi consensus panel on nutritional therapy in chronic kidney disease”. Journal of Nephrology 29.5 (2016): 593-602. | eng |
| dcterms.references | Cuppari L., et al. “A practical approach to dietary interventions for nondialysis-dependent CKD patients: The experience of a reference nephrology center in Brazil”. BMC Nephrology 17.1 (2016): 1-11. | eng |
| dcterms.references | Sánchez C., et al. “Influence of low-protein dietetic foods consumption on quality of life and levels of B vitamins and homocysteine in patients with chronic renal failure”. Nutricion Hospitalaria 25.2 (2010): 238-244. | eng |
| dcterms.references | Espinosa-Cuevas M and Correa-Rotter R. “[Renal alterations and Nutrition] In Arroyo, Kaufer Horowitz, Perez Lizaur (Eds)”. Nutriologia Médica. Buenos Aires. Editorial Panamericana (2015): 695-730. | eng |
| dcterms.references | Bernhard J., et al. “Adaptive response to a low-protein diet in predialysis chronic renal failure patients”. Journal of the American Society of Nephrology 12.6 (2001): 1249-1254 | eng |
| dcterms.references | Walser M and Hill S. “Can renal replacement be deferred by a supplemented very low protein diet?” Journal of the American Society of Nephrology 10.1 (1999): 110-116. | eng |
| dcterms.references | Garneata L., et al. “SP334 Vegetarian very low protein diet supplemented with ketoanalogues may reduce nephrotic-range proteinuria in predialysis CKD patients”. Nephrology Dialysis Transplantation 31.1 (2016): i200-i213 | eng |
| dcterms.references | Noce A., et al. “Is low-protein diet a possible risk factor of malnutrition in chronic kidney disease patients?” Cell Death Discovery 2 (2016): 16026. | eng |
| dcterms.references | Fouque D and Aparicio M. “Eleven reasons to control the protein intake of patients with chronic kidney disease”. Nature Reviews Nephrology 3 (2007): 383-392. | eng |
| dcterms.references | Musso CG and Macías-Núñez JF. “Renal aging and chronic kidney disease in the eldely: which are the differences?” In Musso CG, Jauregui JR, Macías-Núñez JF, Covic A (Eds). Clinical Nephrogeriatrics. An evidence-based guide. Cham. Springer (2019): 13-20. | eng |
| dcterms.references | Menon V., et al. “Effect of a very low-protein diet on outcomes: Long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study”. American Journal of Kidney Diseases 53 (2009): 208-217. | eng |
| dcterms.references | Malvy D., et al. “Effects of severe protein restriction with ketoanalogues in advanced renal failure”. Journal of the American College of Nutrition 18 (1999): 481-486. | eng |
| oaire.version | info:eu-repo/semantics/publishedVersion | spa |